Isoimmunisation in pregnancy: diagnosis, treatment and prevention

1985 ◽  
pp. 129-137 ◽  
Author(s):  
J. Bennebroek Gravenhorst ◽  
D. G. Woodfield
Keyword(s):  
Pregnancy Diagnosis ◽  
Treatment And Prevention ◽  
In Pregnancy

Progestogens for treatment and prevention of pregnancy disorders

2010 ◽  
Vol 3 (3) ◽  
Author(s):  
Adolf E. Schindler
Keyword(s):  
Premature Birth ◽  
Previous History ◽  
First Trimester ◽  
Study Groups ◽  
Treatment And Prevention ◽  
Maternal Immune System ◽  
Hydroxyprogesterone Caproate ◽  
History Of ◽  
Threatened Abortion ◽  
In Pregnancy

AbstractProgesterone appears to be the dominant hormone not only establishing a proper secretory endometrial development but also adequate decidualization to establish pregnancy and sustain pregnancy development. Progesterone is the natural immunoregulator to control the maternal immune system and not to reject the allogeneic fetus. There are two sources of progesterone: corpus luteum first and placenta later. Three progestogens can be used in pregnancy: (i) progesterone (per os, intravaginal and intramuscular), (ii) dydrogesterone (per os), and (iii) 17α-hydroxyprogesterone caproate (intramuscular). There are three indications, for which these progestogens can be clinically used either for treatment or prevention: (i) first trimester threatened and recurrent (habitual) abortion, (ii) premature labor/premature birth, and (iii) pre-eclampsia (hypertension in pregnancy). The available data are limited and only partially randomized. In threatened abortion the use of progesterone, dydrogesterone and 17α-hydroxyprogesterone caproate leads to a significant improved outcome, when at the time of threatened abortion a viable fetus has been ascertained by ultrasound. For prevention of recurrent abortion there are also some data indicating a significant effect compared with women without progestogen treatment. Prevention of preterm birth by progestogens (progesterone vaginally, orally and 17α-hydroxyprogesterone caproate intramuscularly) was significantly effective. The main study groups include pregnant women with a previous history of premature birth. However, also in women with shortened cervix use of progesterone seems to be helpful. The studies done so far in women with risk factors for pre-eclampsia or established pre-eclampsia were based on parenteral progesterone application. However, new studies are urgently needed.

Treatment and prevention of viral hepatitis in pregnancy

2021 ◽  
Author(s):  
Jodie Dionne-Odom ◽  
Gabriella D. Cozzi ◽  
Ricardo A. Franco ◽  
Basile Njei ◽  
Alan T.N. Tita
Keyword(s):  
Viral Hepatitis ◽  
Treatment And Prevention ◽  
In Pregnancy

scholarly journals COMPARISON OF A RAPID TEST WITH bPAG ELISA IN PREGNANCY DIAGNOSIS IN COWS

2021 ◽  
Vol 52 (6) ◽  
pp. 1475-1481
Author(s):  
O. I. Dana ◽  
R. H. Mukhtar ◽  
M. O. Mohammed ◽  
H. O. Dyary
Keyword(s):  
Rapid Test ◽  
Elisa Test ◽  
Urine Samples ◽  
Reference Standard ◽  
Suitable Alternative ◽  
Pregnancy Diagnosis ◽  
Alternative Method ◽  
Blood And Urine Samples ◽  
Calving Intervals ◽  
In Pregnancy

Early pregnancy detection is vital for properly managing livestock farms by re-inseminating nonpregnant females and minimizing the calving intervals. The present investigation was executed to compare a rapid test (Dairy Cow Pregnancy Test from Span Biotech Ltd. Shenzhen, China) with a commercial bPAG ELISA test (IDEXX®) for pregnancy diagnosis in non-descriptive cows. The study also aimed to elucidate if the rapid test could be an alternative method to ELISA in the field. Blood and urine samples were collected from 43 cows to measure the concentrations of bovine pregnancy-associated glycoproteins (bPAGs) in the blood samples and detect progesterone via the rapid test in the urine samples. Examining the genital tracts was achieved after slaughtering the cows to determine the uterus’ state, used as the reference standard for both tests. The results showed that the bPAG ELISA test was more accurate in pregnancy detection than the rapid test. However, there were no statistically significant differences (P > 0.05) between both methods’ results. We conclude that the rapid test can be a suitable alternative method to the bPAG ELISA test for diagnosing pregnancy in cows in field conditions.

Maturity onset diabetes of the young in pregnancy: diagnosis, management and prognosis of MODY in pregnancy

2017 ◽  
Vol 27 (5) ◽  
pp. 144-147
Author(s):  
Kate Rees ◽  
A. Reed ◽  
Anita Banerjee ◽  
Dharmintra Pasupathy
Keyword(s):  
Maturity Onset Diabetes ◽  
Pregnancy Diagnosis ◽  
Onset Diabetes ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document